Segall Bryant & Hamill »

Denali Therapeutics shares owned by Segall Bryant & Hamill

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Segall Bryant & Hamill from 13F filings

Historical chart of Segall Bryant & Hamill investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Segall Bryant & Hamill consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Segall Bryant & Hamill

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.4M 513k 14.52
2025-06-30 $7.0M 501k 13.99
2025-03-31 $3.8M 281k 13.60
2024-12-31 $5.9M 289k 20.38